IPOGrid
0001835205
IPO filing research
IBERE PHARMACEUTICALS
Blank Checks
ipo
priced
424B4
IBERE PHARMACEUTICALS IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: 424B4 on 2021-03-01.
Filing Timeline
SEC EDGAR
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2021-03-01 · 0001104659-21-029859
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2021-02-25 · 9999999995-21-000745
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows CERT and registers the class of securities for exchange listing.
2021-02-25 · 0001104659-21-028004
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2021-02-25 · 0000876661-21-000257
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2021-02-22 · 0001104659-21-026147
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2021-02-09 · 0001104659-21-015548
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2020-12-07 · 0001104659-20-132899
Comparable Deals
1 comparable deal
FinancialsLast 18 months
Only 0 strict matches; expanded to 1 using nearest neighbors.
Recent News
No recent news stored for this issuer.